ACE INHIBITOR USE AND MAJOR CARDIOVASCULAR OUTCOMES IN TYPE 2 DIABETES TREATED WITH THE DPP-4 INHIBITOR ALOGLIPTIN
- Resource Type
- Source
- Journal of the American College of Cardiology. 65:A1411
- Subject
business.industry ACE inhibitor medicine Type 2 diabetes Pharmacology Cardiology and Cardiovascular Medicine business medicine.disease Cardiovascular outcomes Alogliptin Dipeptidyl peptidase-4 medicine.drug - Language
- ISSN
- 0735-1097